
    
      Study design :

      Randomized, double-blind, rasagiline (1 mg) vs placebo study. Parallel group (randomization
      1/1). Duration 3 months 16 recruiting centers in France

      Population :

      50 drug-na√Øve patients with Parkinson's disease, with apathy. 2 groups : 25 patients with
      placebo and 25 patients with rasagiline.

      3 visits

        -  Visit 1 : inclusion / randomisation/ first study medication dispensation

        -  Visit 2 (1.5 month after V1) : first evaluation and second study medication
           dispensation.

        -  Visit 3 (3 months after V1, final visit) : second evaluation
    
  